Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001628280-26-058920

SVP, General Counsel sold 29,697 shares at $2.12 ($62,958)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Douglas Earl Martin SVP, General Counsel 2026-08-21 Sale −29,697 $2.12 $62,958 488,267 D: show line 1 in the form
Open-market sales · 29,697 sh · avg $2.12 · $62,958
Loading xslF345X06/wk-form4_1787690594.xml…